Insider Transactions in Q4 2023 at Kal Vista Pharmaceuticals, Inc. (KALV)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2023
|
Venrock Healthcare Capital Partners Iii, L.P. |
BUY
Open market or private purchase
|
Indirect |
6,013
+0.15%
|
$72,156
$12.49 P/Share
|
|
Dec 28
2023
|
Venrock Healthcare Capital Partners Iii, L.P. |
BUY
Open market or private purchase
|
Indirect |
471,490
+10.34%
|
$5,657,880
$12.5 P/Share
|
|
Dec 27
2023
|
Venrock Healthcare Capital Partners Iii, L.P. |
BUY
Open market or private purchase
|
Indirect |
41,514
+1.14%
|
$456,654
$11.97 P/Share
|
|
Dec 27
2023
|
Thomas Andrew Crockett CEO |
SELL
Open market or private sale
|
Direct |
30,000
-19.04%
|
$360,000
$12.02 P/Share
|
|
Nov 20
2023
|
Thomas Andrew Crockett CEO |
SELL
Open market or private sale
|
Direct |
14,807
-8.59%
|
$118,456
$8.23 P/Share
|
|
Nov 20
2023
|
Benjamin L Palleiko CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
13,008
-10.37%
|
$104,064
$8.23 P/Share
|
|
Nov 20
2023
|
Christopher Yea CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
7,113
-13.38%
|
$56,904
$8.23 P/Share
|
|
Nov 20
2023
|
Edward P. Feener CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
4,958
-5.85%
|
$39,664
$8.23 P/Share
|
|
Nov 20
2023
|
Paul K. Audhya CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,985
-17.92%
|
$63,880
$8.23 P/Share
|
|
Nov 17
2023
|
Thomas Andrew Crockett CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,583
+16.31%
|
-
|
|
Nov 17
2023
|
Benjamin L Palleiko CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
30,197
+19.4%
|
-
|
|
Nov 17
2023
|
Christopher Yea CHIEF DEVELOPMENT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,497
+17.78%
|
-
|
|
Nov 17
2023
|
Edward P. Feener CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,497
+11.94%
|
-
|
|
Nov 17
2023
|
Paul K. Audhya CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
18,530
+29.37%
|
-
|
|
Oct 30
2023
|
Thomas Andrew Crockett CEO |
SELL
Bona fide gift
|
Direct |
8,000
-5.45%
|
-
|